• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

vesicare

  1. Is the ship really sinking?

    Just curious to the state of Astellas? How morale? I heard Vesicare is going generic 2018/2019.